CXXIF
C21 Investments Inc. [CXXIF] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CXXIF Stock Summary
In the News
CXXIF Financial details
Company Rating
Sell
Market Cap
37.7M
Income
-2.58M
Revenue
28.77M
Book val./share
0.28
Cash/share
0.02
Dividend
-
Dividend %
-
Employees
116
Optionable
No
Shortable
Yes
Earnings
31 May 2024
P/E
-13.18
Forward P/E
-
PEG
1.05
P/S
1.18
P/B
1.03
P/C
17
P/FCF
9.76
Quick Ratio
0.17
Current Ratio
0.53
Debt / Equity
0.3
LT Debt / Equity
0.25
-
-
EPS (TTM)
-0.02
EPS next Y
-
EPS next Q
-
EPS this Y
-86.13%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
62.04%
Revenue Q/Q
-3.91%
EPS Q/Q
-11.43%
-
-
-
-
SMA20
-2.78%
SMA50
-12.5%
SMA100
45.83%
Inst Own
0.06%
Inst Trans
0%
ROA
-5%
ROE
-8%
ROC
0.01%
Gross Margin
35%
Oper. Margin
1%
Profit Margin
-9%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.201-0.471
52W High
-
52W Low
-
RSI
47.43
Rel Volume
0.21
Avg Volume
63.71K
Volume
13.23K
Perf Week
-8.85%
Perf Month
-4.6%
Perf Quarter
18.47%
Perf Half Y
13.33%
-
-
-
-
Beta
2.469
-
-
Volatility
0.02%, 0.03%
Prev Close
7.29%
Price
0.34
Change
10.32%
CXXIF Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-01-31
| Metric | History | 2019-01-31 | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.08 | 0.49 | 0.34 | 0.28 | 0.24 | |
| Net income per share | -0.76 | -0.42 | -0.06 | 0.08 | 0.01 | |
| Operating cash flow per share | -0.37 | 0.07 | 0.09 | 0.06 | 0.05 | |
| Free cash flow per share | -0.37 | 0.07 | 0.09 | 0.04 | 0.05 | |
| Cash per share | 0.29 | 0.04 | 0.06 | 0.03 | 0.02 | |
| Book value per share | 0.68 | 0.18 | 0.24 | 0.3 | 0.29 | |
| Tangible book value per share | -0.69 | -0.36 | -0.14 | -0.02 | -0.02 | |
| Share holders equity per share | 0.68 | 0.18 | 0.24 | 0.3 | 0.29 | |
| Interest debt per share | 1.65 | 0.53 | 0.3 | 0.17 | 0.1 | |
| Market cap | 66.31M | 38.1M | 127.23M | 53.24M | 30.67M | |
| Enterprise value | 107.16M | 71.09M | 148.29M | 68.84M | 40.92M | |
| P/E ratio | -2.81 | -1.17 | -20.84 | 5.35 | 22.2 | |
| Price to sales ratio | 25.65 | 1.01 | 3.52 | 1.61 | 1.06 | |
| POCF ratio | -5.83 | 6.91 | 12.82 | 7.79 | 5.2 | |
| PFCF ratio | -5.73 | 7.62 | 13.12 | 12.46 | 5.62 | |
| P/B Ratio | 3.14 | 2.81 | 5.02 | 1.52 | 0.89 | |
| PTB ratio | 3.14 | 2.81 | 5.02 | 1.52 | 0.89 | |
| EV to sales | 41.45 | 1.89 | 4.1 | 2.09 | 1.42 | |
| Enterprise value over EBITDA | -9.74 | 17.73 | 11.8 | 5.89 | 6.54 | |
| EV to operating cash flow | -9.43 | 12.9 | 14.94 | 10.07 | 6.94 | |
| EV to free cash flow | -9.25 | 14.22 | 15.29 | 16.11 | 7.5 | |
| Earnings yield | -0.36 | -0.85 | -0.05 | 0.19 | 0.05 | |
| Free cash flow yield | -0.17 | 0.13 | 0.08 | 0.08 | 0.18 | |
| Debt to equity | 2.37 | 2.66 | 1.08 | 0.53 | 0.35 | |
| Debt to assets | 0.64 | 0.59 | 0.4 | 0.3 | 0.21 | |
| Net debt to EBITDA | -3.71 | 8.23 | 1.68 | 1.34 | 1.64 | |
| Current ratio | 0.58 | 0.3 | 0.99 | 0.7 | 0.58 | |
| Interest coverage | -8.69 | -0.23 | 1.68 | 7.46 | 8.66 | |
| Income quality | 0.48 | -0.17 | -2.65 | 0.52 | 4.27 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 3.42 | 0.27 | 0.21 | 0.24 | 0.28 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.55 | 0.67 | 0.57 | 0.61 | 0.62 | |
| Capex to operating cash flow | 0.02 | -0.09 | -0.02 | -0.37 | -0.07 | |
| Capex to revenue | -0.08 | -0.01 | -0.01 | -0.08 | -0.02 | |
| Capex to depreciation | -0.24 | -0.1 | -0.07 | -1.41 | -0.19 | |
| Stock based compensation to revenue | 1.77 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Graham number | 3.41 | 1.3 | 0.56 | 0.75 | 0.27 | |
| ROIC | -0.09 | -0.02 | 0.2 | 0.12 | 0.02 | |
| Return on tangible assets | -0.68 | -1.61 | -0.21 | 0.41 | 0.06 | |
| Graham Net | -1.38 | -0.53 | -0.32 | -0.18 | -0.16 | |
| Working capital | -13.32M | -26.95M | -144.72K | -4.44M | -6.23M | |
| Tangible asset value | -21.51M | -27.67M | -14.16M | -2.78M | -2.11M | |
| Net current asset value | -37.86M | -36.21M | -27.89M | -16.59M | -15.25M | |
| Invested capital | 2.37 | 2.66 | 1.08 | 0.53 | 0.35 | |
| Average receivables | 46.02K | 261.54K | 326.5K | 210.15K | 311.37K | |
| Average payables | 752.59K | 1.27M | 1.26M | 1.39M | 1.62M | |
| Average inventory | 4.36M | 8.16M | 7.18M | 5.41M | 4.11M | |
| Days sales outstanding | 11.29 | 4.29 | 2.12 | 2.33 | 5.21 | |
| Days payables outstanding | 212.38 | 17.02 | 28.88 | 36.12 | 43.41 | |
| Days of inventory on hand | 1.33K | 113.77 | 141.16 | 104.42 | 98.36 | |
| Receivables turnover | 32.34 | 85.09 | 172.14 | 156.75 | 70.06 | |
| Payables turnover | 1.72 | 21.45 | 12.64 | 10.11 | 8.41 | |
| Inventory turnover | 0.28 | 3.21 | 2.59 | 3.5 | 3.71 | |
| ROE | -1.12 | -2.4 | -0.24 | 0.28 | 0.04 | |
| Capex per share | -0.01 | -0.01 | 0 | -0.02 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-10-31 for Q3
| Metric | History | 2022-10-31 | 2023-01-31 | 2023-04-30 | 2023-07-31 | 2023-10-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | |
| Net income per share | 0 | -0.01 | 0 | 0 | 0 | |
| Operating cash flow per share | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Free cash flow per share | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Cash per share | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Book value per share | 0.31 | 0.29 | 0.28 | 0.28 | 0.28 | |
| Tangible book value per share | 0.01 | -0.02 | -0.02 | -0.02 | -0.02 | |
| Share holders equity per share | 0.31 | 0.29 | 0.28 | 0.28 | 0.28 | |
| Interest debt per share | 0.12 | 0.1 | 0.09 | 0.08 | 0.08 | |
| Market cap | 26.66M | 30.67M | 30.82M | 35.29M | 32.17M | |
| Enterprise value | 38.1M | 40.92M | 40.02M | 42.94M | 40.08M | |
| P/E ratio | 26.82 | -5.46 | -19.9 | -21.21 | -21.38 | |
| Price to sales ratio | 3.7 | 4.36 | 4.01 | 4.93 | 4.67 | |
| POCF ratio | 18.49 | 25.55 | 25.28 | 20.93 | -315.79 | |
| PFCF ratio | 18.64 | 25.75 | 26.17 | 23.78 | -89.07 | |
| P/B Ratio | 0.71 | 0.89 | 0.91 | 1.06 | 0.97 | |
| PTB ratio | 0.71 | 0.89 | 0.91 | 1.06 | 0.97 | |
| EV to sales | 5.29 | 5.82 | 5.2 | 6 | 5.82 | |
| Enterprise value over EBITDA | 20.88 | 138.73 | 39.67 | 62.55 | 56.79 | |
| EV to operating cash flow | 26.43 | 34.09 | 32.82 | 25.46 | -393.45 | |
| EV to free cash flow | 26.63 | 34.35 | 33.99 | 28.93 | -110.97 | |
| Earnings yield | 0.01 | -0.05 | -0.01 | -0.01 | -0.01 | |
| Free cash flow yield | 0.05 | 0.04 | 0.04 | 0.04 | -0.01 | |
| Debt to equity | 0.36 | 0.35 | 0.33 | 0.3 | 0.3 | |
| Debt to assets | 0.22 | 0.21 | 0.19 | 0.18 | 0.18 | |
| Net debt to EBITDA | 6.27 | 34.73 | 9.12 | 11.13 | 11.21 | |
| Current ratio | 0.73 | 0.58 | 0.57 | 0.55 | 0.53 | |
| Interest coverage | 13.94 | -10.87 | 17.76 | 53.29 | 0 | |
| Income quality | 6.07 | -0.85 | -3.15 | -4.25 | 0.29 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.3 | 0.27 | 0.15 | 0.21 | 0.26 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.6 | 0.62 | 0.64 | 0.64 | 0.64 | |
| Capex to operating cash flow | -0.01 | -0.01 | -0.03 | -0.12 | 2.55 | |
| Capex to revenue | 0 | 0 | -0.01 | -0.03 | -0.04 | |
| Capex to depreciation | -0.02 | -0.01 | -0.09 | -0.42 | -0.53 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.12 | 0.27 | 0.14 | 0.15 | 0.14 | |
| ROIC | 0 | -0.02 | -0.02 | -0.01 | -0.01 | |
| Return on tangible assets | 0.01 | -0.06 | -0.02 | -0.02 | -0.02 | |
| Graham Net | -0.15 | -0.16 | -0.16 | -0.15 | -0.15 | |
| Working capital | -3.9M | -6.23M | -6.14M | -6.35M | -6.41M | |
| Tangible asset value | 910.68K | -2.11M | -2.2M | -2.29M | -2.32M | |
| Net current asset value | -13.01M | -15.25M | -14.75M | -14.85M | -14.78M | |
| Invested capital | 0.36 | 0.35 | 0.33 | 0.3 | 0.3 | |
| Average receivables | 246K | 336.58K | 533.8K | 598.76K | 445.21K | |
| Average payables | 1.4M | 1.61M | 1.72M | 1.61M | 1.56M | |
| Average inventory | 5.48M | 4.86M | 3.84M | 3.28M | 2.94M | |
| Days sales outstanding | 3.26 | 5.28 | 7.67 | 6.81 | 4.55 | |
| Days payables outstanding | 37.47 | 30.8 | 28.96 | 33.66 | 32.84 | |
| Days of inventory on hand | 151.2 | 69.78 | 63.61 | 63.13 | 61.88 | |
| Receivables turnover | 27.63 | 17.06 | 11.74 | 13.21 | 19.76 | |
| Payables turnover | 2.4 | 2.92 | 3.11 | 2.67 | 2.74 | |
| Inventory turnover | 0.6 | 1.29 | 1.41 | 1.43 | 1.45 | |
| ROE | 0.01 | -0.04 | -0.01 | -0.01 | -0.01 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
CXXIF Frequently Asked Questions
What is C21 Investments Inc. stock symbol ?
C21 Investments Inc. is a CA stock , located in Vancouver of Bc and trading under the symbol CXXIF
What is C21 Investments Inc. stock quote today ?
C21 Investments Inc. stock price is $0.34 today.
Is C21 Investments Inc. stock public?
Yes, C21 Investments Inc. is a publicly traded company.
Company Profile
- Volume Average 63.71K
- Market Capitalization 37.7M
- Employee 116
- CEO Mr. Sonny Newman
- Headquarters Vancouver,BC,CA
- IPO Date 2018-06-22
-
Website
https://www.cxxi.ca 
C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. It offers packaged and wholesale flower, vaporizer pens, cured extracts, edibles, pre-rolls, tinctures, and topicals; and payroll and benefits services. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 Investments Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada.
